Fig. 2From: A three-gene expression-based risk score can refine the European LeukemiaNet AML classificationCategorized TriAS predicts overall survival of AML patients. Kaplan-Meier survival analysis of pooled patients from the TCGA data set and enrolled into AMLCG-1999 (GSE12417-GPL570) (training set) (a) and two additional validation sets from either NTUH (b) or AMLCG-1999 (c) based on TriAS categories are shownBack to article page